Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-24 @ 11:25 PM
NCT ID:
NCT03057756
Eligibility Criteria:
Inclusion criteria:
* Aged 15 years and above
* Never been treated with second line anti-TB drugs for more than one month,
* Give written consent to participate
* Agree to be hospitalised for at least four months in specialised healthcare
* Willing to adhere to ambulatory directly observed treatment by a healthcare worker;
Exclusion criteria:
* Pregnant during inclusion process
* Presented with altered clinical status condition as judged by the clinician
* Knowing of history of hypersensitivity reaction to any of the drugs to be used
* Baseline ECG does not show a QT space superior to 500ms
* Refusal to participate into study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT03057756
Study Brief:
Protocol Section:
NCT03057756